WELLESLEY, Mass., Sept. 14, 2017 /PRNewswire/ -- Andrew Hertler, MD, FACP, Chief Medical Officer of New Century Health (NCH) was a faculty member at the Clinical Pathways Congress 2017 in Washington, D.C. The 3-day conference, which started on September 8th and ran until September 10th, focused on the expansion of oncology clinical pathways and their increasing influence on patient care.
The second annual Clinical Pathways Congress convened senior thought leaders from across the cancer care spectrum to discuss clinical pathways and their impact on improved patient outcomes, quality, and cost. During his presentation, The Integration of Genomics into Clinical Pathways, Dr. Hertler shared insights about the role clinical pathways can play as a decision support tool in assisting physicians with the selection of appropriate molecularly driven therapy. In addition, Dr. Hertler addressed alternative strategies for the incorporation of genomics into clinical pathways.
"Considering the rapid advances occurring in 'Precision Medicine', there is a critical need to ensure that oncologists have the right tools to select the right therapies to drive better patient outcomes," said Dr. Atul Dhir, Chief Executive Officer of New Century Health.
About New Century Health
New Century Health is the nation's leading specialty care management company, with special focus on cancer and cardiology patients. We partner with specialist providers and health plans to provide them with the clinical decision and population health management tools to ensure that cancer and cardiology patients receive the highest quality, most affordable care. To learn more about New Century Health, please visit www.newcenturyhealth.com
SOURCE New Century Health
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article